PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1996 | 1 |
| 1997 | 1 |
| 1999 | 1 |
| 2000 | 3 |
| 2001 | 5 |
| 2002 | 4 |
| 2003 | 13 |
| 2004 | 16 |
| 2005 | 30 |
| 2006 | 70 |
| 2007 | 85 |
| 2008 | 158 |
| 2009 | 207 |
| 2010 | 251 |
| 2011 | 300 |
| 2012 | 277 |
| 2013 | 264 |
| 2014 | 211 |
| 2015 | 248 |
| 2016 | 275 |
| 2017 | 258 |
| 2018 | 306 |
| 2019 | 223 |
| 2020 | 232 |
| 2021 | 303 |
| 2022 | 198 |
| 2023 | 167 |
| 2024 | 151 |
| 2025 | 154 |
| 2026 | 111 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Oncogene"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Correction: Novel exosomal circEGFR facilitates triple negative breast cancer autophagy via promoting TFEB nuclear trafficking and modulating miR-224-5p/ATG13/ULK1 feedback loop.
- Song H, Zhao Z, Ma L, Zhao W, Hu Y, Song Y.
- Oncogene. 2026 Nov;45(43):4718-4721. doi: 10.1038/s41388-026-04010-5.
- PMCID: PMC13683045
Song H, et al.Oncogene. 2026.PMCID: PMC13683045 -
CircLAMA5 traps Sam68 in the cytoplasm to regulate alternative splicing and drive sunitinib resistance in ccRCC.
- Xu Z, Lu H, Lu Z, Wang R, Zhu Z, Ding Y, Li Y, Lu Y, Li F, Luo W, Lin Y, Mao X, Xu C, Chen Y, Yan Z, Huo G, Zhou Z, Xu M, Ding L, Li G, Xia L.
- Oncogene. 2026 Sep 15;45(43):4673-4688. doi: 10.1038/s41388-026-03981-9.
- PMCID: PMC13683050
Xu Z, et al.Oncogene. 2026.PMCID: PMC13683050 -
ITGA5 promotes homologous recombination mediated radioresistance in esophageal squamous cell carcinoma by upregulating RAD51AP1 expression.
- Huang X, Liu J, Ren J, Yuan J, Huo W, Zhang Z, Chen M, Tian B, Chen D.
- Oncogene. 2026 Sep 4;45(42):4564-4580. doi: 10.1038/s41388-026-03966-8.
- PMCID: PMC13661274
Huang X, et al.Oncogene. 2026.PMCID: PMC13661274 -
The RNA-binding protein La/SSB is associated with HNSCC progression and TFAP2C/FSCN1-linked transcriptional regulation.
- Liu S, Chen D, Zhang W, Li H, Peng J, Wang X, Zhang M, Liu W, Zhang J, Wang M, Han G, Cai C, Liu S, You X, Xu Q, Han Y, Zha X, Ma S.
- Oncogene. 2026 Sep 3;45(42):4533-4550. doi: 10.1038/s41388-026-03959-7.
- PMCID: PMC13661278
Liu S, et al.Oncogene. 2026.PMCID: PMC13661278 -
The GSEC-encoded polypeptide GESP drives colorectal cancer tumorigenesis via NPM1-c-Myc-mediated repression of NDRG1.
- Kawasaki Y, Hayashi T, Kitta-Kunihiro A, Negishi L, Suda S, Furuya-Ikude C, Taniguchi N, Akiyama T, Kondo E.
- Oncogene. 2026 Sep 1;45(42):4522-4532. doi: 10.1038/s41388-026-03958-8.
- PMCID: PMC13661239
Kawasaki Y, et al.Oncogene. 2026.PMCID: PMC13661239 -
Beyond the blood-brain barrier: humanised mice, the missing link in glioblastoma research.
- Shirazi Nia R, Lu J, De Vega D, Poudine N, Pan C, Zhou F, Ji J, Giamas G.
- Oncogene. 2026 Sep 20;45(41):4347-4361. doi: 10.1038/s41388-026-03989-1.
- PMCID: PMC13645632
Shirazi Nia R, et al.Oncogene. 2026.PMCID: PMC13645632 -
Decitabine suppresses triple-negative breast cancer by disrupting DNMT1 liquid-liquid phase separation and synergizes with G9a inhibition.
- Hu M, Peng H, Qiu G, Liu S, Li Q, Liang T, Lai J, Liang F, Zhu Y, Liu X, Xie L, Liu Y, Chen T, Zhang B, Rao H, Xiao S, Li P, Ma X, Chen X.
- Oncogene. 2026 Aug 26;45(41):4420-4441. doi: 10.1038/s41388-026-03971-x.
- PMCID: PMC13645674
Hu M, et al.Oncogene. 2026.PMCID: PMC13645674 -
Epithelial interferon-stimulated gene programs modulate chemotherapy sensitivity in colorectal cancer via EPSTI1.
- Erkan EP, Hämäläinen E, Kolikova J, Nikupaavola T, Sajnani K, Kuc K, Ojala K, Kukkonen M, Hermelo I, Kurttila A, Koskensalo S, Tarvainen T, Leppä A, Keränen I, Haapamäki C, Karjalainen E, Carpelan-Holmström M, Renkonen-Sinisalo L, Koskenvuo L, Puolakkainen P, Mecklin JP, Väyrynen JP, Virolainen E; iCAN; Nykter M, Aaltonen LA, Urbanucci A, Lepistö A, Ristimäki A, Seppälä TT.
- Oncogene. 2026 Aug 21;45(41):4377-4392. doi: 10.1038/s41388-026-03957-9.
- PMCID: PMC13645637
Erkan EP, et al.Oncogene. 2026.PMCID: PMC13645637 -
Correction: Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer.
- Zhao C, Jiang L, Wang MY, Tang QY, Zhao JW, Yang ZY, Gu J, Song XL, Dong P, Pan LJ, Shu YJ, Gong W.
- Oncogene. 2026 Oct;45(40):4345. doi: 10.1038/s41388-026-03999-z.
- PMCID: PMC13600931
Zhao C, et al.Oncogene. 2026.PMCID: PMC13600931 -
Complementary intra- and extracellular AGR2 activities support epithelial ovarian cancer cell aggressiveness.
- Guilbard M, Taouji S, Aubry M, Robert J, Pineau R, Velasco V, Florent R, Weiswald LB, Hartog C, Lebreton C, Coulon A, Croce S, Babin G, Chaveroux C, Beq S, Chevet E, Fessart D, Delom F.
- Oncogene. 2026 Aug 10;45(40):4215-4235. doi: 10.1038/s41388-026-03938-y.
- PMCID: PMC13600914
Guilbard M, et al.Oncogene. 2026.PMCID: PMC13600914